SironRX Therapeutics

SironRX Therapeutics

closed
SironRX is developing novel therapies that promote dermal wound repair and reduce scarring.

Launch date
Employees
Market cap
-
Enterprise valuation
€12—19m (Dealroom.co estimates Aug 2011.)
Cleveland Ohio (HQ)
  • Edit
DateInvestorsAmountRound

$500k

Seed

$3.4m

Series A
Total Funding€3.5m

Recent News about SironRX Therapeutics

Edit